Basic & Clinical Cancer Research 2017. 9(3):23-31.

Association of Hypoxia-inducible factor α subunits with TSGA10 transcripts in HeLa, MCF7 and MDA-MB231- cell lines
Parya Rahmani Rad, Maryam Beigom Mobasheri, Morteza Hashemzadeh-Chaleshtori, Mohammad Hossein Modarressi


Background: Hypoxia is a common phenomenon in cancer cells, related to angiogenesis and cell proliferation the hypoxia-inducible factor family (HIFs) is the primary transcriptional factor to hypoxic stress. Cancer-testis (CT) antigens are almost expressed in male germ cells, aberrantly expresses in some malignancies as well. The CT gene, TSGA10, prevents the nuclear accumulation of HIF-α and may be involved in organ-specific regulation of hypoxic gene expression during sperm maturation. TSGA10 is supposed to regulate the HIF expression in germ cells and cancer cells. The HIF-α subunit has three isoforms, involved in oxygen transport, angiogenesis and tumor metastasis, which their detection is the subject of the current study.

Methods: Three cell lines, MCF7, MDA-MB-231 and HeLa were cultured, passaged and categorized into normal and synchronized groups. The cells were subjected to RNA extraction and reverse-transcribed into cDNAs. Real time RT-PCR was performed to amplify TSGA10 and HIF-α isoforms and HPRT, as the normalizer gene, using appropriate primers. The REST and SPSS software were used for statistical analysis.

Results: The expression of three isoforms of HIF-α in HeLa cell line was higher than MCF7, and MCF7 was higher than MDA-MB-231. Moreover, the expression relationship between HIF-α isoforms and TSGA10 was evaluated in each three cell lines as well. The results were significant in all cases with P =0.01. Before and after synchronization in each three cell lines, the isoform expressions of HIF-α and TASGA10 were evaluated, and the results were revealed their dependent expression. The relationship between HIF-α isoforms and TSGA10 expression was compared with each other. The cell lines with less TSGA10 expression had the higher expression of HIF-α isoforms and vice versa, according to the extent of TSGA10.

Conclusion: The significant relationship between expressions of TSGA10 and HIF-α isoforms is confirmed. 


TSGA10; HIF-α subunits; Cancer-Testis genes; breast cancer cell lines; MCF7; MDA-MB-231

Full Text:



Modarressi MH, Cameron J, Taylor KE, Wolfe J. Identification and characterization of a novel gene, TSGA10, expressed in testis. Gene. 2001; 262(1-2):249-55.

Farzaneh Rahmani Rad, Maryam Beigom Mobasheri, Mohammad Hossein Modarressi. TSGA10, as a Cancer/Testis gene: review article. Tehran Univ Med J 2015; 73(4): 231-242

Dianatpour M, Mehdipour P, Nayernia K, Mobasheri MB, Ghafouri-Fard S, Savad S, Modarressi MH. Expression of testis specific genes TSGA10, TEX101 and ODF3 in breast cancer. Iran Red Crescent Med J. 2012; 14(11):722-6.

Salehipour P, Nematzadeh M, Mobasheri MB, Afsharpad M, Mansouri K, Modarressi MH. Identification of new TSGA10 transcript variants in human testis with conserved regulatory RNA elements in 5'untranslated region and distinct expression in breast cancer. Biochim Biophys Acta: 2017; 1860 (9):973-982.

Mobasheri MB, Modarressi MH, Shabani M, Asgarian H, Sharifian RA, Vossough P, et al. Expression of the testis-specific gene, TSGA10, in Iranian patients with acute lymphoblastic leukemia (ALL). Leukemia research: 2006; 30(7):883-9.

- Li Y, Li J, Wang Y, Zhang Y, Chu J, Sun C, Fu Z, Huang Y, Zhang H, Yuan H, Yin Y. Roles of cancer/testis antigens (CTAs) in breast cancer. Cancer Letter. 2017: 28; 399: 64-73.

Hagele S, Behnam B, Borter E, Wolfe J, Paasch U, Lukashev D, et al. TSGA10 prevents nuclear localization of the hypoxia-inducible factor (HIF)-1alpha. FEBS letters. 2006;580(15):3731-8

- Mansouri K, Mostafie A, Rezazadeh D, Shahlaei M, Modarressi MH. New function of TSGA10 gene in angiogenesis and tumor metastasis: a response to a challengeable paradox. Human Molecular Genetics. 2016:15;25(2):233-44

Semenza GL. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene. 2010;29(5):625-34.

Niu F, Li Y, Lai FF, Chen XG. Research progress of hypoxia-inducible factor 1 inhibitors against tumors. Yao xue xue bao . Acta pharmaceutica Sinica: 2014;49(6):832-6.

- Mobasheri MB, Shirkoohi R, Zendehdel K, Jahanzad I, Talebi S, Afsharpad M, Modarressi MH. Transcriptome analysis of the cancer/testis genes, DAZ1, AURKC, and TEX101, in breast tumors and six breast cancer cell lines. Tumour Biol 2015; 36:8201-8206

Maryam Beigom Mobasheri, Reza Shirkoohi, Mohammad Hossein Modarressi. Synaptonemal Complex Protein 3 Transcript Analysis in Breast Cancer. Iran J Public Health. 2016 Dec; 45(12): 1618–1624.

Kazemi-Oula G, Ghafouri-Fard S, Mobasheri MB, Geranpayeh L, Modarressi MH. Upregulation of RHOXF2 and ODF4 Expression in Breast Cancer Tissues. Cell Journal. 2015;17(3):471-7

Mobasheri MB, Shirkoohi R, Modarressi MH. Cancer/Testis OIP5 and TAF7L Genes are Up-Regulated in Breast Cancer. Asian Pacific J Cancer Prevention 2015; 16:4623-4628.

Miryounesi M, Nayernia K, Mobasheri MB, Dianatpour M, Oko R, Savad S, Modarressi MH. Evaluation of in vitro spermatogenesis system effectiveness to study genes behavior: monitoring the expression of the testis specific 10 (Tsga10) gene as a model. Arch Iran Med 2014 ;17:692-7

Vordermark D. Expression of hypoxia-inducible factor-1alpha in oligodendrogliomas: its impact on prognosis and on neoangiogenesis. Cancer. 2002;94(8):2317-8; author reply 8-9.

Dales JP, Garcia S, Meunier-Carpentier S, Andrac-Meyer L, Haddad O, Lavaut MN, et al. Overexpression of hypoxia-inducible factor HIF-1alpha predicts early relapse in breast cancer: retrospective study in a series of 745 patients. International journal of cancer Journal international du cancer. 2005;116(5):734-9.

Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, Oberhuber G. Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer research. 2000;60(17):4693-6.

Birner P, Schindl M, Obermair A, Breitenecker G, Oberhuber G. Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research. 2001;7(6):1661-8.

Giatromanolaki A, Koukourakis MI, Sivridis E, Turley H, Talks K, Pezzella F, et al. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. British journal of cancer. 2001;85(6):881-90.

Beasley NJ, Leek R, Alam M, Turley H, Cox GJ, Gatter K, et al. Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. Cancer research. 2002;62(9):2493-7.

Hu H, Takano N, Xiang L, Gilkes DM, Luo W, Semenza GL. Hypoxia-inducible factors enhance glutamate signaling in cancer cells. Oncotarget. 2014;5(19):8853-68.

- Ortmann B, Druker J, Rocha S. Cell cycle progression in response to oxygen levels. Cellular and molecular life sciences : CMLS. 2014;71(18):3569-82.

- Badr S, Salem A, Yuosif AH, Awadallah H, Awed N, Bakr A. Hypoxia inducible factor-1alpha and microvessel density as angiogenic factors in bilharzial and non-bilharzial bladder cancer. Clinical laboratory. 2013;59(7-8):805-12.

Saponaro C, Malfettone A, Ranieri G, Danza K, Simone G, Paradiso A, et al. VEGF, HIF-1alpha expression and MVD as an angiogenic network in familial breast cancer. PloS one. 2013;8(1):e53070.

Powis G, Kirkpatrick L. Hypoxia inducible factor-1alpha as a cancer drug target. Molecular cancer therapeutics. 2004;3(5):647-54.

Ke Q, Costa M. Hypoxia-inducible factor-1 (HIF-1). Molecular pharmacology. 2006;70(5):1469-80.

To C, Farnsworth RH, Vail ME, Chheang C, Gargett CE, Murone C, et al. Hypoxia-Controlled EphA3 Marks a Human Endometrium-Derived Multipotent Mesenchymal Stromal Cell that Supports Vascular Growth. PloS one. 2014;9(11):e112106.

Chen YT, Ross DS, Chiu R, Zhou XK, Chen YY, Lee P, et al. Multiple cancer/testis antigens are preferentially expressed in hormone-receptor negative and high-grade breast cancers. PloS one. 2011;6(3):e17876.


  • There are currently no refbacks.

Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.